共 79 条
- [1] Xu Y(2013)Prevalence and control of diabetes in Chinese adults J Am Med Assoc 310 948-59
- [2] Wang L(2017)Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study Br J Ophthalmol 101 1591-5
- [3] He J(1991)Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12 Ophthalmology 98 823-33
- [4] Bi Y(2011)Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy Acta Ophthalmol 89 e567-572
- [5] Li M(2016)Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy Int J Ophthalmol 9 1772-8
- [6] Wang T(2018)Ranibizumab plus panretinal photocoagulation versus panretinal photocoagulation alone for high-risk proliferative diabetic retinopathy (PROTEUS study) Ophthalmology 125 691-700
- [7] Zhang G(2017)Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy Pak J Med Sci 33 142-5
- [8] Chen H(2017)Single-dose intravitreal bevacizumab after complete panretinal photocoagulation in proliferative diabetic retinopathy: an effective adjunctive treatment Med Hypothesis Disco Innov Ophthalmol 6 76-81
- [9] Chen W(2018)Efficacy and safety of intravitreal conbercept, ranibizumab, and triamcinolone on 23-gauge vitrectomy for patients with proliferative diabetic retinopathy J Ophthalmol 2018 4927259-43
- [10] Zhang M(2016)Intravitreal conbercept (Kh902) for surgical treatment of severe proliferative diabetic retinopathy Retina 36 938-2402